200 related articles for article (PubMed ID: 4906733)
21. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
Kálmán B; Lublin FD
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
[TBL] [Abstract][Full Text] [Related]
22. Further studies on the pathogenic mechanisms of multiple sclerosis with a proposal for a therapeutic approach.
Campbell B; Vogel PJ
Trans Am Neurol Assoc; 1969; 94():234-6. PubMed ID: 4313960
[No Abstract] [Full Text] [Related]
23. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
Alvord EC
Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
[No Abstract] [Full Text] [Related]
24. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
25. [Chronic experimental allergic encephalomyelitis in adult rhesus macaques].
D'iakonova IN; Ravkina LI; Matveeva TV; Kamzeev VD; Krasnova VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):40-5. PubMed ID: 7124222
[No Abstract] [Full Text] [Related]
26. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
Brown A; McFarlin DE; Raine CS
Lab Invest; 1982 Feb; 46(2):171-85. PubMed ID: 7062721
[TBL] [Abstract][Full Text] [Related]
27. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
Raine CS; Traugott U; Nussenblatt RB; Stone SH
Lab Invest; 1980 Mar; 42(3):327-35. PubMed ID: 7189001
[TBL] [Abstract][Full Text] [Related]
28. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials.
Campbell B; Vogel PJ; Fisher E; Lorenz R
Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365
[No Abstract] [Full Text] [Related]
29. Animal models for multiple sclerosis.
Owens T
Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
[No Abstract] [Full Text] [Related]
30. [Multiple sclerosis. Current status of research. II].
Lhermitte F; Lyon-Caen O
Rev Neurol (Paris); 1983; 139(6-7):395-406. PubMed ID: 6612147
[No Abstract] [Full Text] [Related]
31. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
32. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
Hofstetter HH; Toyka KV; Gold R
Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
[TBL] [Abstract][Full Text] [Related]
33. Auto-allergies of the central nervous system: a review.
Thomson JD
J Iowa Med Soc; 1969 Dec; 59(12):1085-92. PubMed ID: 4901764
[No Abstract] [Full Text] [Related]
34. [Aspects of the value of humoral antibodies in encephalomyelitis of neuroallergic origin].
Hitzschke B; Günther J; Meyer-Rienecker HJ
Psychiatr Neurol Med Psychol (Leipz); 1975 Jan; 27(1):1-15. PubMed ID: 178016
[TBL] [Abstract][Full Text] [Related]
35. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
[TBL] [Abstract][Full Text] [Related]
36. Experimental allergic encephalomyelitis and neuritis: immunologic responses to myelin basic proteins.
Brostoff SW
Birth Defects Orig Artic Ser; 1978; 14(5):245-60. PubMed ID: 687794
[No Abstract] [Full Text] [Related]
37. An ultrastructural study of experimental demyelination and remyelination. IV. Recurrent episodes and peripheral nervous system plaque formation in experimental allergic encephalomyelitis.
Raine CS; Wisniewski H; Dowling PC; Cook SD
Lab Invest; 1971 Jul; 25(1):28-34. PubMed ID: 4397530
[No Abstract] [Full Text] [Related]
38. [Myelinotoxic activity of sera from animals with experimental allergic encephalomyelitis in organotypic cultures of the rat cerebellum at different stages of differentiation].
Perevozchikova MF
Biull Eksp Biol Med; 1981 Apr; 91(4):469-71. PubMed ID: 7260366
[TBL] [Abstract][Full Text] [Related]
39. Experimental allergic encephalomyelitis: inhibition of myelination and remyelination.
Bornstein MB; Raine CS
Neurology; 1970 Apr; 20(4):389. PubMed ID: 5535013
[No Abstract] [Full Text] [Related]
40. [Multiple sclerosis. 3. Gliotoxic factors].
Berg O; Källén B
Lakartidningen; 1970 Jul; 67(29):3292-6. PubMed ID: 4916239
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
